AG
ABBV icon

Advisor Group’s AbbVie ABBV Stock Holding History

Advisor Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$27M Buy
304,741
+20,248
+7% +$1.68M 0.19% 100
2019
Q3 		$21.6M Buy
284,493
+21,474
+8% +$1.47M 0.16% 114
2019
Q2 		$19.1M Buy
263,019
+14,231
+6% +$1.12M 0.15% 120
2019
Q1 		$20.1M Buy
248,788
+10,166
+4% +$832K 0.17% 110
2018
Q4 		$22M Buy
238,622
+17,941
+8% +$1.58M 0.22% 80
2018
Q3 		$20.9M Buy
220,681
+37,486
+20% +$3.55M 0.21% 90
2018
Q2 		$17M Sell
183,195
-7,192
-4% -$702K 0.23% 84
2018
Q1 		$18M Sell
190,387
-1,663
-0.9% -$183K 0.25% 79
2017
Q4 		$18.6M Buy
192,050
+5,528
+3% +$521K 0.25% 80
2017
Q3 		$16.6M Buy
186,522
+5,053
+3% +$385K 0.26% 76
2017
Q2 		$13.2M Buy
181,469
+19,695
+12% +$1.32M 0.23% 91
2017
Q1 		$10.5M Buy
161,774
+17,886
+12% +$1.12M 0.21% 98
2016
Q4 		$9.01M Sell
143,888
-9,024
-6% -$551K 0.2% 109
2016
Q3 		$9.65M Sell
152,912
-4,780
-3% -$309K 0.23% 96
2016
Q2 		$9.76M Buy
+157,692
New +$9.61M 0.26% 88

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Advisor Group's ABBV Position: Q4 2019 in Review

Advisor Group increased its AbbVie (ABBV) stake by 7.1% in Q4 2019, buying an estimated $1.68M and bringing the position to 304,741 shares worth $27M. The position accounts for 0.19% of the portfolio, ranked #100.

Advisor Group first reported a position in ABBV in Q2 2016 and has held it in 15 quarters since. 2,243 funds tracked by Wall St. Rank hold ABBV as of Q4 2019.

  • Advisor Group held 304,741 shares of AbbVie worth $27M as of Q4 2019.
  • Advisor Group bought 20,248 AbbVie shares in Q4 2019, an estimated $1.68M.
  • AbbVie made up 0.19% of Advisor Group's portfolio in Q4 2019, its #100 holding.
  • Advisor Group first reported a position in AbbVie in Q2 2016 and has held it in 15 quarters since.
  • 2,243 funds tracked by Wall St. Rank held AbbVie as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.